Collaboration leverages Engitix’s human ECM Platform to identify high-confidence targets for liver fibrosis regressionLONDON, June 08, 2026 (GLOBE NEWSWIRE) -- Engitix Ltd. (“Engitix”), a ...
MedPage Today on MSN
Cardiac amyloidosis diagnosis gets a more extensive AI model
Clinical, lab parameters coupled with echo data in AI-ECM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results